Valuation IMPACT Therapeutics, Inc

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:18 2026-06-23 EDT			5-day change	1st Jan Change
36.24 ^HKD	-2.74%		-1.74%	-

06-07	Impact Therapeutics Nets HK$120 Million From Full Exercise of IPO Overallotment Option	MT
06-01	Impact Therapeutics, Inc Presents Phase 1/2 Clinical Data for Imp1734 At 2026 Asco Annual Meeting	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2026	2027	2028
Market Cap ¹	8,647	-	-
Change	-	-	-
Enterprise Value (EV) ¹	7,814	7,369	7,191
Change	-	-5.7%	-2.42%
P/E	-	-	-
PBR	-	-	-
PEG	-	-	-
Capitalization / Revenue	31.2x	9.19x	11.3x
EV / Revenue	28.2x	7.83x	9.41x
EV / EBITDA	-55.6x	17.4x	57.6x
EV / EBIT	-54.6x	17.5x	59.3x
EV / FCF	-	-	-
FCF Yield	-	-	-
Dividend per Share ³	-	-	-
Rate of return	-	-	-
EPS ³	-	-	-
Distribution rate	-	-	-
Net sales ¹	277.5	941.3	763.9
EBITDA ¹	-140.6	424.5	124.9
EBIT ¹	-143.2	421.3	121.2
Net income	-	-	-
Net Debt ¹	-832.3	-1,277	-1,456
Reference price ³	36.24	36.24	36.24
Nbr of stocks (in thousands)	276,165	-	-
Announcement Date	-	-	-

¹HKD in Million²CNY in Million³

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IMPACT THERAPEUTICS, INC	-	34.08x	-67.28x	-	1.31B
LONZA GROUP AG	30.2x	5.35x	16.57x	1.09%	43.24B
REVOLUTION MEDICINES, INC.	-20.85x	310.12x	-19.1x	-.--%	35.25B
BEONE MEDICINES AG	40.55x	4.04x	25.86x	-.--%	30.22B
IQVIA HOLDINGS INC.	20.42x	2.41x	10.42x	-.--%	28.01B
CELLTRION, INC.	28.37x	7.35x	18.9x	0.44%	24.08B
MEDPACE HOLDINGS, INC.	26.74x	4.27x	19.45x	-.--%	13.01B
EUROFINS SCIENTIFIC SE	22.04x	1.91x	8.4x	1.21%	12.7B
IONIS PHARMACEUTICALS, INC.	-21.01x	13.85x	-20.61x	-.--%	12.54B
Average	15.81x	42.60x	-0.82x	0.34%	22.26B
Weighted average by Cap.	17.16x	59.03x	7.91x	0.37%